The Pathobyte Series: Escherichia coli- Friend or Foe?

BugSpeaks

Feb 04, 2026

•

7 min read

•

MicroByte Series

First identified in 1884, Escherichia coli is a versatile Gram-negative bacterium capable of existing as a harmless commensal or causing severe disease. Driven by the acquisition of mobile genetic elements and potent toxins, it adapts to diverse niches, spreading through contaminated food, water, and medical devices. Infections range from intestinal watery diarrhea and hemorrhagic colitis to life-threatening extraintestinal conditions, including urinary tract infections, sepsis, and meningitis. Accurate diagnosis leverages traditional biochemical testing alongside modern PCR-based assays. While treatment typically restricts antibiotic therapy to avoid resistance and severe systemic complications, robust prevention relies heavily on strict hygiene and rigorous sterilization protocols.

History and naming

Escherichia coli (E. coli) is one of the most popular, versatile, and well-studied bacteria on the planet. It is ubiquitous in nature, and different strains of E. coli are responsible for both health and disease. Beyond its role in human health, non-pathogenic strains of E. coli are widely used as model organisms in research. Researchers and students in the life sciences, at least once in their academic journey, have been best friends with E. coli, as it can be conveniently grown and handled in the laboratory. We owe the discovery of this bacterium to the German microbiologist and pediatrician Theodor Escherich.

In 1884, while studying the role of infant gut microbes in digestion and disease, Escherich discovered a fast-growing bacterium and named it Bacterium coli commune. Later, in 1988, it was renamed Escherichia coli in his honour.

Escherichia coli is an extremist. Some strains of E. coli are beneficial to human health, while others can cause serious infections. An important question is how such friendly, non-pathogenic bacteria become pathogenic foes.

An important question is how such friendly, non-pathogenic bacteria become pathogenic foes. E. coli’s ability to adapt to diverse niches and its remarkable versatility act as a double-edged sword. While these adaptive capabilities allow E. coli to survive in a wide range of environments, they can also pose a significant risk to human health. By acquiring new genetic material from its environment or from other bacteria and viruses, E. coli can transform from a harmless commensal into a pathogenic organism, making it harmful and, at times, truly dangerous to humans.

Non-pathogenic strains- Friendly or harmless variants of a microbe that do not cause disease and often live peacefully inside a host body.

Genetic material- The DNA or RNA that acts as an organism's hereditary blueprint, carrying all the instructions for its traits and daily functions.

Pathogenesis

Escherichia coli (E. coli) is not inherently pathogenic, as it is a part of the normal gut microflora and exists as a commensal organism. However, depending on the type and combination of foreign DNA it acquires, different strains of E. coli can become pathogenic. These pathogenic strains differ in their mechanisms of infection, the toxins they produce, and the types of infections they cause, resulting in a wide range of clinical symptoms.

E. coli can cause both intestinal infections and extraintestinal infections (infections occurring outside the intestine).

Gut microflora- The massive community of beneficial bacteria, fungi, and other microbes that naturally live inside the intestines to aid digestion.

Toxins- Poisonous substances produced by living organisms (like bacteria) that cause physical harm, cellular damage, or disease inside the host.

Intestinal Infections

Intestinal infections are caused by five major pathotypes of E. coli:

Enteroinvasive E. coli (EIEC)

EIEC is genetically, biochemically, and pathologically similar to Shigella species. It occasionally causes dysentery and inflammatory colitis, but more commonly results in diarrhoea. The virulence factors of EIEC are encoded on acquired plasmids, such as the mxi and spa genes, which encode components of the secretion system and proteins required to deliver toxins into host cells.

Inflammatory colitis- Severe inflammation, irritation, and swelling of the inner lining of the large intestine (colon), usually causing intense pain and diarrhea.

Plasmids- Small, circular pieces of DNA found in bacteria that are separate from the main chromosome and can be easily shared with other bacteria to pass on new traits.

Enteropathogenic E. coli (EPEC)

A specific region of DNA known as the locus of enterocyte effacement (LEE) is responsible for the unique mechanism by which EPEC infects host epithelial cells. This process, called “attaching and effacing,” involves the bacterium attaching to epithelial cells, destroying microvilli, and altering cell structure. As a result, intestinal inflammation, increased intestinal permeability, and active ion secretion occur, ultimately leading to watery diarrhoea.

Locus of enterocyte effacement- A specific cluster of bacterial genes that gives the microbe the molecular weapons needed to attach to and destroy the surface of intestinal cells.

Epithelial cells- The tightly packed cells that line the internal and external surfaces of the body, acting like a protective shield for organs like the gut.

Microvilli- Tiny, microscopic, finger-like projections on the surface of intestinal cells that drastically increase surface area for absorbing nutrients.

Intestinal permeability- A measure of how easily fluids and substances slip through the gut lining into the bloodstream; an abnormal increase leads to a "leaky gut."

Ion secretion- The process where cells pump charged minerals (like sodium or chloride) out into tissues or the gut, which naturally pulls water along with them.

Enterohaemorrhagic E. coli (EHEC) / Shiga toxin–producing E. coli (STEC)

This strain carries genes that encode Shiga toxin along with LEE. When Shiga toxin enters the bloodstream, it can damage the kidneys and lead to hemolytic uremic syndrome. Within the intestine, it damages colonic cells, resulting in intestinal perforation, necrosis, haemorrhagic colitis, and bloody diarrhoea.

Shiga toxin- A highly dangerous toxin produced by certain bacteria that completely shuts down cell protein production and rips open blood vessels in the gut and kidneys.

Hemolytic uremic syndrome- A life-threatening medical emergency caused by toxins that destroy red blood cells, clog the body's filtering system, and lead to sudden kidney failure.

Necrosis- The premature death of body tissue or cells caused by injury, lack of blood supply, or severe bacterial poisoning.

Haemorrhagic colitis- A severe form of colon inflammation marked by intense abdominal cramps and bloody diarrhea due to bleeding in the gut wall.

Enterotoxigenic E. coli (ETEC)

ETEC is a common cause of travellers’ diarrhoea. It harbours genes that encode enterotoxins, which are of two main types: heat-labile toxin (LT) and heat-stable toxin (ST). A strain may produce either one or both toxins. The LT toxin resembles cholera toxin and increases chloride ion secretion while inhibiting absorption, leading to diarrhoea. ST toxins consist of two unrelated classes, STa and STb. STa is associated with human disease and contributes to increased ion secretion, resulting in diarrhoea.

Heat-labile toxin (LT)- A bacterial toxin that causes severe diarrhea but is easily broken down and completely inactivated by high heat or cooking.

Heat-stable toxin (ST)- A rugged bacterial toxin that causes diarrhea and remains fully active and poisonous even when heated or cooked.

Enteroaggregative E. coli (EAEC)

EAEC adheres to epithelial cells in the colon and secretes toxins. Both pathogenic and non-pathogenic strains exhibit a characteristic “stacked-brick” pattern of aggregation and adherence, which gives this pathotype its name. Multiple virulence factors may be produced by EAEC, making it difficult to identify a single toxin responsible for pathogenicity. Recent studies suggest that the transcriptional activator AggR regulates the expression of several virulence factors, proteins, and toxins involved in diarrhoea, and therefore can be used as a marker for identifying pathogenic EAEC strains.

Mobile genetic elements, including plasmids, transposons, bacteriophages, and pathogenicity islands, drive the evolution of pathogenic E. coli by introducing, deleting, or rearranging virulence genes, giving rise to strains that cause diarrhoea, dysentery, haemolytic uremic syndrome, urinary tract infections, and meningitis.

Aggregation- The process of individual microbes sticking together to form tight clumps or protective clusters on tissues or surfaces.

Adherence- The ability of a germ to firmly stick, glue, or anchor itself to a biological surface, like the lining of the bladder or intestines.

Transcriptional activator- A specialized protein that acts like a cellular "on-switch" to activate specific genes so the cell starts manufacturing targeted proteins.

Transposons- Small segments of DNA, often called "jumping genes," that can physically move or copy themselves from one location in a genome to another.

Bacteriophages- Specialized, naturally occurring viruses that hunt, infect, and destroy specific strains of bacteria.

Meningitis- A severe, life-threatening inflammation of the protective membranes (meninges) covering the brain and spinal cord.

Extraintestinal Infections

Uropathogenic E. coli (UPEC)

Uropathogenic E. coli is responsible for urinary tract infections and harbours a variety of virulence genes that aid in the successful infection of the urethra and kidneys. These strains most likely first colonize the gut and then translocate to the periurethral region. Alternatively, infection can be acquired in hospital settings through the insertion of urinary catheters, where the bacteria ascend the urethra and establish themselves in the urinary tract. UPEC produces several virulence factors, such as adhesins and toxins, which cause inflammation and damage to renal epithelial cells.

Virulence genes- Specific pieces of DNA that carry the instructions for a germ's weapons, allowing it to invade hosts, evade immunity, and inflict damage.

Periurethral region- The delicate tissue area immediately surrounding the urethra (the tube that carries urine out of the body).

Adhesins- Surface proteins or structures on a bacterium that act like hooks or Velcro, enabling it to latch tightly onto host cells.

Renal epithelial cells- The specialized cells that line the inner filtering tubes and delicate internal structures of the kidneys.

Meningitis- and sepsis-associated E. coli (MNEC)

When a pathogenic strain of E. coli enters the bloodstream, it can cause bacteremia and may eventually lead to meningitis or sepsis. MNEC strains possess specific genes encoding virulence factors that enable them to cross the blood–brain barrier and bind to brain endothelial cells. These genes are typically absent in non-pathogenic strains of E. coli.

Bacteremia- The presence of live bacteria inside the bloodstream, which can potentially spread the infection to other major organs.

Sepsis- A life-threatening medical emergency triggered by the body’s extreme, overwhelming inflammatory response to an infection, causing widespread organ damage.

Blood–brain barrier- A highly selective, protective wall of cells and blood vessels that prevents harmful chemicals, toxins, and germs in the blood from entering the brain.

Transmission

Ingestion of foods such as undercooked meat and raw vegetables contaminated with pathogenic strains of E. coli can lead to infection. E. coli infections can also be acquired in hospital settings through the use of unsterilised catheters, ventilators, and other medical devices.

Signs and Symptoms

Symptoms of E. coli infection usually begin within 16 hours of ingesting contaminated food. Clinical manifestations vary depending on the pathogenic strain involved. Intestinal infections may cause watery diarrhoea or dysentery, often accompanied by fever and abdominal cramps. A burning sensation or pain during urination, along with an increased urge to urinate, is commonly associated with urinary tract infections.

Diagnosis

In cases of severe or prolonged symptoms, stool tests are performed to identify the causative organism. Currently, PCR-based assays are widely used for diagnosis and are considered reliable. Previously, stool culture followed by specific biochemical tests was used to identify particular strains of E. coli based on their metabolic characteristics.

PCR-based assays- Highly precise lab tests that act like molecular copy machines to rapidly detect the unique DNA of specific germs from a patient's sample.

Biochemical tests- Lab experiments that identify a bacterial species by analyzing its specific chemical reactions, nutrient usage, and waste products.

Treatment

For mild E. coli infections, anti-diarrhoeal medications and rehydration therapy are recommended as the first line of treatment. Antibiotics are generally avoided, as E. coli can rapidly develop antibiotic resistance, which may have serious consequences for patient health.

In cases of severe diarrhoeal illness requiring hospitalisation, antibiotics such as rifaximin, azithromycin, or ciprofloxacin may be recommended. However, antibiotic therapy is only prescribed for certain pathogenic strains. For example, antibiotics are not recommended for infections caused by EHEC/STEC, especially in children and the elderly, due to the increased risk of developing hemolytic uremic syndrome.

Prevention

E. coli infections can be prevented by thoroughly cooking meat, washing fruits and vegetables with purified water, and practising regular hand hygiene. Inimmunocompromised individuals who are at higher risk of infection, prophylactic antibiotics such as rifaximin or bismuth subsalicylate may be considered, but only when prescribed by a physician. Regular sterilisation of medical devices and strict adherence to hygiene protocols in hospitals can further reduce the risk of ventilator-associated pneumonia and catheter-associated urinary tract infections.

Immunocompromised- Having a significantly weakened or damaged immune system, making it much harder for the body to fight off infections and illnesses.

Prophylactic antibiotics- Preventive prescription medications given to a patient to stop an infection from taking root before it even has a chance to start.

Microbe profile

Shape: Rod-shaped/Bacilli

Gram nature: Gram-negative

Spore formation: No

Biofilm formation: Yes

Oxygen requirement: facultative anaerobe

Optimal temperature: 37°C

Optimal pH: wide range of pH(2 -10)

Nutrient usage/Laboratory culture media: McConkey, Eosin Methylene Blue (EMB) Agar

Taxonomic classification

Domain: Bacteria

Kingdom: Pseudomonadati

Phylum: Pseudomonadota

Class: Gammaproteobacteria

Order: Enterobacterales

Family: Enterobacteriaceae

Genus: Escherichia

Species: Escherichia coli

-Khushi. C

Reference

Mueller, M., Rausch-Phung, E. A., & Tainter, C. R. (2025, December 14). Escherichia coli Infection. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK564298/

Kaper, J. B., Nataro, J. P., & Mobley, H. L. T. (2004). Pathogenic Escherichia coli. Nature Reviews Microbiology, 2(2), 123–140. https://doi.org/10.1038/nrmicro818

PATHOGEN

E.COLI

Frequently Asked Questions

How does a harmless, friendly E. coli bacterium transform into a dangerous pathogen?

It transforms by acquiring new foreign genetic material from its environment, including mobile elements like plasmids, transposons, and bacteriophages. This horizontal gene transfer introduces aggressive virulence genes and toxins that allow the bacteria to colonize new areas and damage host tissues.

Why are antibiotics strictly avoided when treating Enterohaemorrhagic E. coli (EHEC/STEC) infections?

Killing these specific bacteria with antibiotics triggers a massive, sudden release of dangerous Shiga toxins straight into the patient's bloodstream. In vulnerable populations like young children and the elderly, this toxic surge significantly increases the risk of sudden kidney failure via hemolytic uremic syndrome.

What unique mechanism allows Enteropathogenic E. coli (EPEC) to cause severe watery diarrhoea?

EPEC utilizes a specialized genetic cluster called the locus of enterocyte effacement to firmly lock onto intestinal epithelial cells. This "attaching and effacing" process completely flattens the protective microvilli, driving up intestinal permeability and forcing massive fluid secretion.

How do Uropathogenic E. coli (UPEC) strains successfully trigger urinary tract infections?

These strains typically migrate from the gut to the periurethral region or enter the urinary tract directly through contaminated medical catheters. Once inside, they deploy specialized hook-like surface structures called adhesins to anchor themselves tightly to renal epithelial cells, causing localized inflammation.

What is the primary difference between the heat-labile (LT) and heat-stable (ST) toxins produced by ETEC?

Heat-labile toxins are fragile proteins that are easily broken down and completely inactivated when exposed to high cooking temperatures. Conversely, heat-stable toxins are highly rugged molecules that remain fully intact, active, and poisonous even after being thoroughly heated or cooked.

BugSpeaks®

BugSpeaks®, developed by Leucine Rich Bio Pvt Ltd, South Asia’s first microbiome company, is headquartered in Bengaluru, India. Since 2014, the company has pioneered advanced analytics to analyze complex genomics data. Collaborating with leading research institutes globally, Leucine Rich Bio has leveraged its expertise to create BugSpeaks®, South Asia’s first gut microbiome test.

Visit Site